In September 2019, the Centers for Medicare and Medicaid Services (CMS) awarded the Washington State Health Care Authority (HCA) a grant under the §1003 SUPPORT ACT. To support this effort, a current state assessment was conducted in state fiscal year (SFY) 2017–2019 to gain insight into the prevalence of substance use disorder (SUD) diagnoses, utilization of treatment services, and physical health and social outcomes among Medicaid beneficiaries with behavioral health diagnoses. However, the COVID-19 pandemic and subsequent public health emergency (PHE) may have impacted prevalence rates, treatment utilization, and use of acute SUD-related services. This set of four updated reports covers an updated time frame including the peak of the pandemic, SFY 2019–2022. Each report addresses a core question about behavioral health treatment and recovery support services in Washington and the potential impact of the COVID-19 PHE on those services.
Report and/or Additional Information:
Categories:
Related Publications:
- Frequency of Substance Use Disorder-Related Acute Events and Services Used After SUD-Related Acute Events (9.126)
- Predicting Receipt of Substance Use Disorder Treatment Among Medicaid Clients (4.111)
- Synthetic Estimates of Substance Use Treatment Need in Washington State (4.112)
- Washington State Behavioral Health Treatment and Recovery Support Services Utilization (9.119)
- Washington State Jail-based Opioid Treatment Networks: Disparities in Initiation of MOUD Treatment (13.05)